Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma 🔗 Access full article via Journal for ImmunoTherapy of CancerShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
